when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

6,918 products tracked

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Phase 2
huMNC2-CAR44
Human Epidermal Growth Factor Receptor 2 Negative Breast… Minerva Biotechnologies Corp
Marketed
human papillomavirus (virus like particle, 9-valent) vaccine
Gardasil 9
Cervical Intraepithelial Neoplasia (CIN)$MRK Merck & Co., Inc.
Marketed
hydralazine
Hydralazine Hydrochloride (hydralazine [INN])
Idiopathic (Essential) Hypertension Teva Pharmaceuticals USA Inc

page 184 of 231

Marketed

hydrochlorothiazide

Hydrochlorothiazide (hydrochlorothiazide [INN])

Edema

Ipca Pharmaceuticals Inc

Phase 1

hydrocodone [INN]

Opium (Opioid) Addiction Elysium Therapeutics Inc

Marketed

hydrocortisone butyrate

Locoid (hydrocortisone butyrate)

Atopic Dermatitis (Atopic Eczema) Bausch Health Americas Inc

Marketed

hydrocortisone valerate

Hydrocortisone Valerate

Atopic Dermatitis (Atopic Eczema) Cosette Pharmaceuticals Inc

Marketed

hydroflumethiazide

Saluron (hydroflumethiazide [INN])

Edema Shire Pharmaceuticals Inc

Marketed

hydrogen peroxide

hydrogen peroxide [USP]

Cervical Cancer Kortuc Japan LLC

Marketed

hydroxocobalamin

Cyanokit (hydroxocobalamin)

Poisoning BTG International Inc

Marketed

hydroxychloroquine

Hydroxychloroquine Sulfate (hydroxychloroquine [INN])

Malaria Creekwood Pharmaceutical Inc

Phase 2

hydroxyprogesterone caproate

Hydroxyprogesterone Caproate (hydroxyprogesterone caproate [INN])

Premature Labor (Tocolysis)$LPCN Lipocine Inc.

Marketed

Xromi (hydroxyurea)

Sickle Cell Disease With Vaso-Occlusive Crisis Nova Laboratories Ltd

Phase 2

Primary Sclerosing Cholangitis Halo Biosciences Inc

Marketed

hymenoptera venom allergen extract

White Faced Hornet Hymenoptera Venom Multidose

Allergies Jubilant HollisterStier LLC

Marketed

hyoscine methobromide

Methscopolamine Bromide (hyoscine methobromide [INN])

Peptic Ulcers AACE Pharmaceuticals Inc

Phase 3

hypericin sodium

hypericin sodium

Cutaneous T-Cell Lymphoma$SNGX SOLIGENIX, INC.

Preclinical

iDose Next Generation

Glaucoma$GKOS GLAUKOS Corp

Preclinical

Type 1 Diabetes (Juvenile Diabetes) iTolerance Inc

Preclinical

Ocular Inflammation iView Therapeutics Inc

Preclinical

Coronavirus Disease 2019 (COVID-19) iX Biopharma Ltd

Phase 2

iadademstat [INN]

Small-Cell Lung Cancer Oryzon Genomics SA

Phase 3

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytope…$NVS NOVARTIS AG

Marketed

Trogarzo (ibalizumab-uiyk)

Human Immunodeficiency Virus (HIV) Infections (AIDS) Theratechnologies Inc

Phase 2

ibcasertib [INN]

Breast Cancer Shenzhen Chipscreen Biosciences Co Ltd

Phase 2

Clostridioides difficile Infections (Clostridium difficil…$ACXP Acurx Pharmaceuticals, Inc.

Phase 3

ibramvibart [INN]

Coronavirus Disease 2019 (COVID-19)$IVVD Invivyd, Inc.

Phase 3

ibrilatazar [INN]

Metastatic Pancreatic Cancer Ability Pharmaceuticals SL

Marketed

ibritumomab tiuxetan

Zevalin (ibritumomab tiuxetan)

B-Cell Non-Hodgkin Lymphoma Acrotech Biopharma Inc

Marketed

Imbruvica (ibrutinib)

Follicular Lymphoma$ABBV AbbVie Inc.